Hemoadsorption in the critically ill - Final results of the International CytoSorb Registry
الحاوية / القاعدة: | PLoS One 17(2022)10, S. e0274315 |
---|---|
المؤلفون الرئيسيون: | Hawchar, Fatime (مؤلف), Tomescu, Dana (مؤلف), Henzler, Dietrich (مؤلف) |
التنسيق: | مقال |
اللغة: | English |
منشور في: |
2022
|
الموضوعات: | |
الوصول للمادة أونلاين: | https://doi.org/10.1371/journal.pone.0274315 |
مواد ذات صلة: | In:
PLoS One |
مواد مشابهة
-
Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement
بواسطة: Köhler, Thomas, وآخرون
منشور في: (2021) -
Hemoadsorption with CytoSorb and the early course of linezolid plasma concentration during septic shock
بواسطة: Köhler, Thomas, وآخرون
منشور في: (2022) -
Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb-Basics, Indications and Perspectives-A Scoping Review
بواسطة: Köhler, Thomas, وآخرون
منشور في: (2021) -
High-dose CytoSorb hemoadsorption is associated with improved survival in patients with septic shock : a retrospective cohort study
بواسطة: Schultz, Philipp, وآخرون
منشور في: (2021) -
Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry
بواسطة: Al-Batran, Salah-Eddin, وآخرون
منشور في: (2021)